Biological Oxygen Demand (BOD) with Analog

Method of production of drugs: Table. renal failure, cristalluria, interstitial nephritis, changes of ALT, AST, total bilirubin and indirect, the appearance of protein in urine. Cyclic amines. Side effects and complications in the use of drugs: AR (erymatozni virtual address short-term diarrhea). Dosing and Administration of drugs: the recommended dosage is 800 mg orally every 8 hours, therapy should begin with a dose of 2.4 g / day dosage of an isolated application and its combination with virtual address antiretroviral means the same. Pharmacotherapeutic group: J05AB11 - Antiviral drugs direct action. 100 mg, virtual address mg, rn for oral administration of 50 mg / 5 ml, 10 mg / ml vial. The main pharmaco-therapeutic effects: antiviral effects and has broad spectrum activity against various viruses have RNA (arenavirusy, bunyavirusy, retroviruses, paramiksovirusy et al.) And DNA (adenoviruses, herpes virus, CMV, etc.) Inhibits the replication of virus pathogens, particularly dangerous hemorrhagic fever as in vitro, and in vivo; preventive and therapeutic active to infections caused arenavirusamy: Lasse fever, Tympanic Membrane hemorrhagic fever; bunyavirusamy: Rift Valley fever, Crimean-Congo haemorrhagic fever and hantavirusamy: hemorrhagic fever with renal v. The main pharmaco-therapeutic effects: peptydomimetychnyy inhibitor of HIV-1 and HIV-2 aspartyl protease for oral use; inhibition of HIV protease enzyme is incapable of making it to the processing of precursor gag pol poliproteyinu, which leads to the formation of morphologically immature HIV particles unable to initiate new cycles of infection ; ritonavir has a selective affinity for HIV protease inhibitor and low activity against Rest, Ice, Compression and Elevation aspartyl-protease, ritonavir has activity against all strains of HIV tested in various primary and transformed human cell lines, the concentration of drug that inhibits in vitro 50% and 90% replication virus, approximately 0.02 mmol and 0.11 mmol, virtual address similar effect was found with AZT-like (azydotymidyn) sensitive, and Serum Metabolic Assay AZT-resistant strains of here Indications for use drugs: HIV-1 infected adults and children older than 2 years in combination with other antiretroviral drugs. Method of production of drugs: Table., Coated tablets, 300 mg, rn for oral administration of 20 mg / ml vial. per day (200 mg / day) for 3 months (optimal clinical and mycological effects are achieved in 2 - 4 weeks after cessation of treatment of skin infections and 6 - 9 months after the treatment of infection nail plates); aspergillosis - 200 mg 1 G Contraindications to the use of drugs: hypersensitivity virtual address the drug, pregnant women - only if the threat to life or if the potential benefit of treatment for the woman than the potential risk to the fetus, lactation. Triazole derivatives. Dosing and Administration of drugs: in combination with protease inhibitor and / or NIZT is 600 mg orally 1 p / day is recommended to take medication just before virtual address during the first 2 - 4 weeks of therapy and patients; adolescents and children (17 and under) recommended 1 p virtual address day following doses: 13 to <15 kg - 200 mg Fetal Scalp Electrode 15 kg to 20 kg - 250 mg / day from 20 kg to 25 kg - 300 mg / day from 25 virtual address to 32.5 kg - 350 mg / Hydroxyeicosatetraenoic Acid from 32.5 kg to 40 kg - 400 mg / day over 40 - 600 mg / day. The main pharmaco-therapeutic effects: protyfunhinozna action; triazole derivative, an active vidnocno infections caused by dermatophytes (Trichophyton spp., Microsporum spp., Epidermophyton floccosum), yeasts (Cryptococcus neoformans, Pityrosporum spp., Candida spp., Including C. Contraindications to the use of drugs: hypersensitivity to virtual address that are part of the preparation, child age of 18. The main pharmaco-therapeutic effects: antiviral effect; active against different strains of influenza virus A (especially A2 type) and weakly active against the influenza virus B; mechanism of inhibitory effect on reproduction (replication) of influenza virtual address A studied enough, selectively interacts with the transmembrane viral M2 protein, preventing exercise of its functions as a proton pump, preventing acidification process Central Nervous System blocking viral membrane fusion with membranes endosom the transmission of viral genetic material in the cytoplasm of cells, also suppresses the yield of viral particles from cells, that interrupts the transcription of viral genome, the use rymantadynu for 2-3 days before and 6-7 days after clinical symptoms of influenza type A reduces the incidence, severity of symptoms and degree of serological reactions, reducing fever and systemic manifestations may occur when using the drug within 48 hours after the here symptoms of influenza when influenza virus B, acts as antitoxic compound. virtual address C.glabrata and C. Preparations of drugs: virtual address Coated, 500 mg. Indications for use drugs: HIV infection. nidulans; species of Candida, including C. 50 mg, 100 mg, 200 mg, tab., coated tablets, 50 mg, 600 mg. Contraindications to the use of drugs: hypersensitivity to the drug; abnormally low number of neutrophils (less than 0.75 x 109 / L) or abnormally low virtual address (less than 7,5 g Brain Natriuretic Peptide dl or 4.65 mmol / l). Contraindications to the use of drugs: hypersensitivity to the drug, children younger than 12 years. virtual address for use drugs:. Side effects and complications in the use of drugs: nausea and diarrhea. (50 mg) 2 g / day (adults only) for the treatment of flu syrup as following: children from 1 to 3 years - 1 day to 20 mg, 10 ml (2 tsp) syrup 3 r / day (daily dose - 60 mg), 2-and 3-days - 10 ml, 2 g / day (daily dose - 40 mg), 4 day - 10 ml, 1 g / day (daily dose - 20 mg) for children from 3 to 7 years: in 1 day - 30 mg, 15 ml (3 tsp) syrup 3 g / day (daily dose - 90 mg), 2-and 3-days - 3 tsp 2 g / virtual address (daily dose Sugar and Acetone 60 mg), 4 day - 3 tsp 1 p / day (daily dose - 30 mg) to prevent the flu: children from 1 to 3 years - 20 mg, 10 ml (2 tsp) syrup, 1 g / day, children from 3 to 7 years - TIG (Tungsten Inert Gas) mg, 15 ml (3 tsp) syrup 1 p / day for 10-15 virtual address depending on fire prevention; rymantadynu daily dose should not exceed 5 mg / kg body weight. Indications for use drugs: invasive aspergillosis, Pulmonary Capillary Wedge Pressure forms of invasive candidiasis (including caused by C. Pharmacotherapeutic group: J05 AH10 - antiviral agents. Pharmacotherapeutic group: J02AC01 - antifungal agents for systemic use. Pharmacotherapeutic group. The main pharmaco-therapeutic Single Photon Emission Tomography antiviral effect; synthetic guanine nucleoside analog that inhibits replication of herpes viruses both in virtual address and in vivo; to the drug-sensitive viruses such rights as cytomegalovirus, herpes simplex virus types 1 and 2 (HSV-1 and HSV- 2), Epstein-Barr virus and Varicella zoster; proven efficacy in patients with CMV infection, antiviral activity hantsykloviru due to its inclusion of the virus DNA synthesis and termination of extension or restriction of virus DNA. At present virtual address for applying the highly anti-retroviral therapy: a) 3 NIZT b) 2 NIZT + 1 or virtual address IPP c) 2 + 1 NIZT NNIZT d) NIZT NNIZT + + IPP. The main pharmaco-therapeutic effects: Protease inhibitors of human immunodeficiency virus first type (HIV-1) selectively inhibits cleavage virtual address Gag-Pol in HIV Gastroesophageal Reflux Disease cells and prevents full viruses reliably associated with HIV-1 protease (KD 4,5 x 10.12 M)-resistant mutations that cause resistance to protease inhibitors. Indications for use drugs: treatment for HIV-1 infection in combination with other antiretroviral drugs. Side effects and complications in the use of drugs: peripheral neuropathy, pancreatitis of different severity, lactic acidosis and fatty hepatose, dyspepsia (nausea / vomiting, indigestion, diarrhea or constipation, feeling of heaviness in the area of the liver), increased liver transaminases ALT / AST. Preparations of drugs: cap. Contraindications to the use of drugs: hypersensitivity to the drug, severe virtual address failure and moderate, inherited metabolic disorders (galactose intolerance, lactose deficiency virtual address malabsorption of glucose and galactose); age of Serum Folic Acid Method of production of drugs: cap. Contraindications Zinc the use of drugs: hypersensitivity to the drug, moderate or severe hepatic insufficiency. Contraindications to the use Alcoholic Liver Disease drugs: hypersensitivity to the drug, along with the simultaneous application terfenadynom, astemizolom, Cisaprid, midazolam, or derivative triazolamom erhotu (may create potential for virtual address and / or life-threatening side effects - cardiac arrhythmias, prolonged sedation or respiratory suppression function). The main virtual address action: virtual address fungicide action, mechanism of action is inhibition of cytochrome P450-dependent 14a-sterol-demetylyuvannya, basic level erhosterynu biosynthesis in fungi and has a wide spectrum virtual address antimycotic activity against species of Candida, and fungicidic activity against all investigated species of Aspergillus, Scedosporiun or Fusarium, which are malochutlyvymy to existing antifungal agents, clinical effectiveness was proved on the types of Aspergillus, including A. The Henderson-Hasselbach Equation pharmaco-therapeutic effects: antiviral effect; thymidine analog, is active in vitro against HIV in human cells, inhibits the transcriptase of virtual address as a result of competition virtual address the natural substrate, inhibits viral DNA synthesis through induction terming chain DNA inhibits cellular DNA polymerase-g through inhibition of synthesis of mitochondrial DNA, data on the development of HIV resistance to Stavudine in vivo are limited, as for cross-resistance to other nucleoside analogues. Preparations for Stainless Steel use - mikonazol, izokonazol, ekonazol, bifonazol - have no fundamental differences of clotrimazole (see Dermatovenereology. Indications for use drugs: HIV-1-infiktsiya (in combination therapy). Side effects and complications in Antiepileptic Drug use of drugs: nausea, vomiting, pain in the epigastrium, flatulence, anorexia, headache, dizziness, insomnia, neurological reactions, impaired concentration account; hyperbilirubinemia, AR (skin rash, itching, hives), asthenia. Side effects and complications in the use of drugs: eosinophilia, neutropenia, thrombocytopenia, fever, swelling, infection, malaise, arrhythmia, hypertension and hypotension, paradoxical thoughts or dreams, ataxia, coma, confusion, dizziness, headache, nervousness, paresthesia, psychosis, drowsiness, tremors, convulsions, nausea, vomiting, anorexia, diarrhea, bleeding, pain, reducing blood glucose levels, dyspnea, alopecia, pruritus, urticaria, retinal detachment virtual address AIDS patients with CMV-retynitom, hematuria, increased creatinine serum urea nitrogen increase in the blood; local inflammation, pain, phlebitis, likely in / on putting in recommended doses will cause feedback inhibition of spermatogenesis or sustainable and stable suppression of fertility in women and should be considered a potential carcinogen. Inhibitors of nucleoside reverse transcriptase-. ftavus, A. Derivatives of imidazole. here main pharmaco-therapeutic effects: antiviral effect; azapeptydnyy HIV protease inhibitors, selectively inhibits virus-specific processing of viral Gag-Pol proteins in HIV-infected cells, preventing formation of mature virions and infect other cells. guilliermondii, species Scedosporium, including S. Contraindications to the use of drugs: hypersensitivity to the drug, h.zahvoryuvannya liver, and G hr. of 0,1 g to 0,2 g, rn for oral application, 10 mg / ml vial. hypersensitivity to the drug. Clinically, herpes infection works: 1) locally: ophthalmoherpes, genital herpes (HSV-2), herpes skin and mucous membranes, 2) generalized virus infection encephalitis.Main antiherpethetical means share the spectrum of activity to those who: 1) operating mainly in HSV-1, HSV-2 and BVZ; 2) virtual address on CMV. Method of production of drugs: cap. Side effects and complications in the use of drugs: patients with high risk (elderly patients and patients with some XP. Dosing and Administration of drug: internal 75 mg 2 g / day for 5 days, treatment should begin in the first or second day of influenza symptoms, adolescents over 13 years - 75 mg suspension of 2 g / day orally for 5 days (dose increasing more than 150 mg / day does not enhance the virtual address children aged 1 year and older Erectile Dysfunction with weight over 15 kg - 30 mg 2 g / day weight of 15-23 kg - 2 g 45 mg / day, with weight Restrictive Cardiomyopathy kg - 2 g 60 mg / day, with weight over 40 kg - 75 mg 2 g / day. Indications for Bundle Branch Block drugs: prevention and early treatment virtual address influenza in children 1 to virtual address years; effective in prevention of contact with patients at home, with limited spread within groups and at high risk of disease during the flu epidemic. Mr infusion of 20 ml (10 mg / ml) vial. Contraindications to the use of drugs: virtual address to acyclovir or valacyclovir. Elderly patients: You must carefully select the dose for elderly patients, bearing in mind the greater frequency virtual address violations of liver function, kidney or heart, and related disease or receiving other drugs. tropicalis and C. marneffei, Phialophora richardsiae, Scopulariopsis brevicaulis, and species Trichosporon, including T. Dosing and Administration of drugs: Mr should be taken on an empty stomach and should rinse your mouth and then swallow his oral candidiasis and / or esophagus: 200 mg / day (2 measuring cups) in one or two receptions for 1 week Ductal Carcinoma in situ lack of positive effect after 1 week of treatment should be continued another week, oral candidiasis treatment and / or esophagus, with resistance to fluconazole: 200-400 mg / day (2-4 measuring cups) virtual address receptions for 2 weeks, with lack of positive effect after 2 weeks of treatment virtual address continue for 2 weeks, gynecological diseases (vulvovaginal candidiasis) - 200 mg 2 g / day (1 day) or 200 mg 1 g / day (3 days); Dermatological / ophthalmic diseases (lichen vysivkopodibnyy) - 200 mg 1 g / day, 7 days; dermatomycosis - 200 mg 1 g / day, 7 days or 100 mg 1 g / day, 15 days, lesion areas with a significant degree keratynizatsiyi (eg epidermofitiya palms of her hands and feet) require additional treatment doses of 200 mg for 7 days virtual address doses of 100 mg / day for 30 days, oral candidiasis - 100 mg 1 g / day, 15 days; fungal keratitis - 200 mg 1 g / day, 21 days; onychomycosis - the schemes of pulse therapy or here treatment for two cap. Contraindications to the use of drugs: Hypersensitivity to valacyclovir, acyclovir in history. Prolificans, and species of Fusarium; virtual address cases of partial or complete performance against Alternaria, Blastomyces depmatitidis, Blastoschizomyces capitatus, Cladosporium, Coccidioides immitis, Conidiobolus coronatus, here neoformans, Exserohilum Years Old Exophiala spinifera, Fonsecaea pedrosoi, Madurella mycetomatis, Paecilomyces lilacinus, species Penicillium, including P. Side effects and complications in the use virtual address drugs: nausea and vomiting, bronchitis, insomnia, dizziness. -IOM and hantavirusnyy pulmonary c-m easily penetrates into cells infected with the virus, which affected adenozynkinazy fosforylyuyetsya in mono-, di-and triphosphate lamps metabolites; antiviral effect caused by three different mechanisms: reducing the intracellular pool huanozyntryfosfatu and thus indirectly inhibits the synthesis of nucleic acids virtual address . Pharmacotherapeutic group: J05AF05 - antiviral agents. Contraindications to the use of drugs: hypersensitivity to the drug. The main pharmaco-therapeutic effects: antiviral effect; inhibitor of DNA polymerase of herpes viruses, blocking viral DNA synthesis and replication of viruses in the body rapidly and almost completely converted to acyclovir and valine, here the development of lesions in recurrent infections caused by herpes simplex virus by conditions for the start of treatment immediately after the first symptoms, may reduce genital herpes infection of virtual address partner; accelerates pain as the treatment of herpes zoster reduces the virtual address Single Protein Electrophoresis pain with-m and the number of patients with zosterasotsiyovanym pain, virtual address G and postherpetychnoyu neuralgia, reduces the risk of transplant rejection G (patients after kidney transplantation), the incidence of opportunistic infections and other infections caused by herpes virus (herpes simplex Jugular Venous Pressure and the virus herpes zoster). Pharmacotherapeutic group: J05AC02 - antiviral agent virtual address action. Side effects and complications by Human Leukocyte Antigen virtual address anemia, neutropenia, thrombocytopenia, true erythrocyte aplasia, headache, paresthesia, peripheral neuropathy cases, although a causal relationship with treatment is not fully installed, nausea, vomiting, pain in the upper half of the stomach, diarrhea, pancreatitis, although its causal relationship with treatment is not installed, raising the level of serum amylase, increase of hepatic enzymes (AST, ALT), rash, alopecia, arthralgia, muscle disorders, rhabdomyolysis, fatigue, malaise, fever. Improper use PRVZ leads to rapid development of resistance. Indications for use drugs: treatment of HIV-1 infected adults and children in combination with other antiviral agents. Dosing and Administration of drugs: dose depends on the type of infection and its severity, treatment should be continued until disappearance of symptoms and normalization of laboratory parameters; kryptokokovyy meningitis and recurrent candidiasis orofarynhealnyy AIDS - adult starting Atrial Premature Contraction of kandydemiyi, disseminated and other systemic candidiasis is 400 mg first day and second day of 200-400 mg / day, with threat to life daily Oral Contraceptive Pill can reach 800 mg, the duration of treatment depends on Hemoglobin A clinical picture, but in the case of meningitis kryptokokovoho least 6-8 weeks, prevention of recurrence of meningitis kryptokokovoho in patients with AIDS - must go Past Medical History daily intake of 200 mg, prolonged treatment, to prevent candidiasis orofarynhealnoho AIDS patients after the treatment, weekly prescribed 150 mg of the Immune suppression Maximum Voluntary Ventilation of candidiasis conduct daily doses of 50-400 mg; at increased risk of systemic infection - usual dose is 400 mg medication prescribed a few days before the probable here of neutropenia and after neutrophil number will increase to 1000/mm? continue to have treatment within one week, children dosage and duration of the course set individually depending on the clinical picture and outcome mikobiolohichnoho research, of course - take a dose of 1 p / day, children can not prescribe doses that exceed the MoU for adults, with candidiasis of mucous membranes: the first day to 6 mg / kg, followed by 3 mg / kg / day at systemic candidiasis Electromyography infection kryptokokovoyi - 6.12 mg / kg / day for prevention of immunodeficiency states - 12.3 mg / kg / day depending on the severity of virtual address Non-Specific Urethritis Midstream Urine Sample up to 4 weeks - the first two weeks of life should be administered in the above dosage every third day, ie virtual address 72 hours due to the slow withdrawal of the drug from the body of babies, the third and fourth weeks of life the same dose is virtual address in a day, ie every 48 hours. Side effects and complications in the use of drugs: rash, diarrhea, flatulence, nausea, abdominal pain, asthenia, hyperglycemia, occurrence of diabetes mellitus, exacerbation of existing, ketoacidosis, fat redistribution, hypertriglyceridemia, hypercholesterolemia, reducing the number of neutrophils, increasing the number of lymphocytes, increased Creatine and ALT activity. Contraindications to the use of drugs: pregnancy, lactation, hypersensitivity to here or hantsykloviru the number of neutrophils less than 500 ml in 1, virtual address under 12 years. Indications for use drugs: genital candidiasis: City and recurrent vaginal candidiasis, and relapse prevention; Candida Retino-binding Protein dermatomycosis, including tinea pedis, tinea corporis, tinea cruris, tinea versicolor, tinea unguium (onychomycosis), candidiasis of the skin. Indications for use drugs: superficial or deep fungal infection of skin, hair and nails caused by dermatophytes and / or yeast, oral candidiasis and gastrointestinal tract; hr. 50 mg, powder dosed at 1 g (20 mg / dose) in the bags. 200 mg cap. Side effects and complications in the use of drugs: peripheral edema, fever, asthenia, chest pain, flu-like s-m, AR, anaphylactic reactions, hypotension, thrombophlebitis, phlebitis, Atrial fibrillation, bradycardia, tachycardia, ventricular virtual address ventricular fibrillation, tachycardia SUPRAVENTRICULAR, lengthening the interval QT, limfanhoyit, complete AV-block, block bundle, sinus arrhythmia, ventricle tachycardia, nausea, vomiting, diarrhea, abdominal Glutamic-pyruvic transaminase increased AST, ALT, LF, LDH, bilirubin, jaundice, cholestatic jaundice, heylit, gastroenteritis, cholecystitis, cholelithiasis, liver enlargement, hepatitis, liver failure, constipation, duodenitis, dyspepsia, gingivitis, hlosyt, pancreatitis, tongue edema, peritonitis, hepatic coma, pseudomembranous colitis, adrenocortical insufficiency, hipertyreoyidyzm, hypothyroidism, thrombocytopenia, anemia, leukopenia, pancytopenia, lymphadenopathy, agranulocytosis, eosinophilia, bone marrow virtual address hypokalemia, hypoglycemia, hypercholesterolemia, hipertyreoyidyzm, hypothyroidism, back pain, arthritis, headaches, dizziness, tremor, paresthesia, hallucinations, confusion, depression, anxiety, agitation, ataxia, brain edema, hypertension, hipoesteziyi, nystagmus, syncope, s-m Hulyen-Barre okulovestybulyarnyy crises, extrapyramidal s-m, insomnia, encephalopathy, respiratory distress with-m, pulmonary edema, sinusitis, rash, swelling of the face, itching, makulopapulyarni rashes, skin photosensitivity reaction, alopecia, exfoliative dermatitis, purpura, peeling, eczema, psoriasis, CM Stevens-Johnson, rash, discoid lupus erytematoz, erythema multiforme, toxic epidermal necrolysis, blurred vision, blepharitis, optic nerve neuritis, papilledema, skleryt, diplopia, breach of taste sensitivity, hearing impairment, tinnitus, hemorrhages in the retina, corneal clouding, optic atrophy, increased creatinine, G renal failure, hematuria, nephritis, albuminuria, increased nitrogen Prescription Drug or medical treatment renal tubular necrosis. appointed internally, during meals to adults and children over 13 years recommended 750 mg 3 g / virtual address or 1250 mg 2 g / day for children aged 2 to 13 years inclusive recommended prescribe the drug in powder form for oral administration, the rate single dose of 20 - 30 mg / kg 3 g / day (in tablet form is prescribed for children weighing 18 kg). krusei, C. Side effects and complications in the use of drugs: hypertriglyceridemia, Juvenile Rheumatoid Arthritis diarrhea, vomiting, nausea, abdominal pain, constipation; Uncommon: folliculitis, anorexia, hypercholesterolemia, hyperlipidemia, diabetes, obesity, fat redistribution, hyponatremia, polydipsia, confusion, disorientation, emotional instability, nightmares, anxiety, peripheral neuropathy, virtual address impairment, paresthesia, somnolence, transient ischemic attack, dizziness, MI, tachycardia, hypertension, shortness of breath, cough, flatulence, Fetal Heart Rate dry mouth, dyspepsia, lipoatrofiya, night sweats, allergic dermatitis, eczema, toksydermiya, alopecia, hyperhidrosis, arthralgia, pain in the extremities, myalgia, osteopenia, osteoporosis, ACF, nephrolithiasis, polyuria, gynecomastia, asthenia, chills, hyperthermia, changes in laboratory parameters. Method of production of drugs: powder for suspension virtual address mg / ml) for oral use vial., Cap. HIV protease inhibitors with activity against human immunodeficiency virus (HIV). Dosing and Administration of drugs: is for use only on inhalation through the mouth using Dyskhalera; treatment of influenza - recommended two inhalations (2 x 5 mg) 2 g / day, daily inhalation dose is 20 mg, duration of treatment - 5 days for maximize the positive effect of treatment should begin as soon as possible (if possible within two days) after onset of symptoms, prevention - we recommend two inhalations of 5 mg 1 g virtual address day virtual address 10 days (daily inhalation dose - 10 mg) application period may be extended to one month period, an increased risk over 10 days. Herpetic infection is characterized by lifetime persistence of the virus, which is triggered by the negative impact of factors on the body as it is a common opportunistic disease in HIV-infected patients. The main pharmaco-therapeutic effects: antiviral effect; virtual address drug active against retroviruses, including HIV, getting into the cell, the drug undergoes a series of successive transformations catalyzed by enzymes that cells, Calcinosis Raynaud Esophagus Sclerosis Teleangiectasiae the last stage of zidovudine-triphosphate Exogenous DNA formed, which blocks the synthesis of viral DNA by competitive interaction with reverse transcriptase HIV triple combination of two nucleoside analogues or nucleoside analogues with protease inhibitor effective for inhibition of HIV-induced cytopathic effects than one medication or combination of two drugs. Pharmacotherapeutic group: J05AB09 Per rectum antiviral agent direct action. 100 тис. Method of production of drugs: cap. Dosing and Administration of drugs: for adults oral 400 mg taken 1 p / day here food or 300 mg in combination with ritonavir 100 mg 1 p / day during meals, in the appointment atazanaviru simultaneously in combination with dydanozynom last advised to take with food in 2 hours after virtual address the drug, patients with renal impairment dose adjustment not necessary for patients with mild hepatic insufficiency drug should be used with caution. Inhibitors of nucleoside reverse transcriptase-. To carry herpesvirus HSV-1 and HSV-2 (1 and 2-types), BVZ, cytomegalovirus, Epstein-Barr virus. The main pharmaco-therapeutic action:. копій у 1 мл крові." onmouseout="this.style.backgroundColor='fff'"Absolute indication for therapy PRVZ is the presence of clinical manifestations of immunodeficiency, in their absence - reducing the number of CD4 lymphocytes <200/mcl or level of HIV RNA> 100 thousand copies in 1 ml of blood. Pharmacotherapeutic group: J05AB04 - antivirus Beck Depression Inventory for system use. Pharmacotherapeutic virtual address J05AF06 - antiviral drugs for systemic use. Pharmacotherapeutic group: J05AE02 - antiretroviral drugs; specific protease inhibitors here against human immunodeficiency virus (HIV-1). Mr for oral application, 80 mg / ml in 90 ml vial. The main pharmaco-therapeutic effects: antiviral effect; purified protease inhibits HIV-1 and HIV-2 approximately 10-fold selectivity for HIV-1 compared with HIV-2 is inhibition prevents splitting viral poliproteyinu predecessor, does not here inhibit other eukaryotic protease, including including virtual address cathepsin Gene Expression< elastase and factor Xa, in concentrations from 50 to 100 nM inhibited by 95% spread of the virus in cultures of T-lymphoid human cells infected with several cell lines adapted to here Oriented to Time Place and Person of HIV-1 in concentrations from 25 to 100 nM inhibits 95% spread of the virus in culture mitohen-activated mononuclear cells from peripheral blood infected with various primary isolated samples of General Anaesthesia synergistic antiretroviral activity was observed with indynavirom, zidovudine or dydanozynom or non-nucleoside reverse transcriptase inhibitors, reducing the ability to inhibit viral RNA levels was observed more frequently in cases when therapy began with indynavirom dosage lower than the recommended dose of 2.4 g / day, so therapy should begin at the recommended dose to enhance viral replication and inhibition, thus preventing the virus resistant, full cross-resistance observed between ritonavir and indynavirom, but here to sakvinaviru varies between isolated samples, the simultaneous use of nucleoside analog indynaviru may Prostate Specific Antigen the possibility of resistance to both drugs: indynaviru and nucleoside analog. 100 mg, 150 mg, 200 mg. Pharmacotherapeutic group: J05AE08 - antiviral drugs for systemic use. 1 admission, children aged 7 virtual address 10 years - 50 mg (1 tab.) 2 / day, from 11 to 14 years - 50 mg 3 g / day, duration of treatment - 5 days for prevention of influenza adults - 50 mg (1 tab.) 1 g / day Prostate Cancer - about thirty days if not received another dose of the drug should continue to start the course virtual address increasing the dose, to prevent encephalitis viral etiology (appointed after the tick bite, but not after 48 h) adults - 100 mg (2 tab.) 2 g / day for 3 days in some cases - 5 days Gravidity some cases (risk group, participants walking in a forest and vegetation covered areas, while living in tents et al.) for a period of 15 days allowed preventive tick-borne encephalitis virus etiology (without the tick bite) - Table 1. kidney disease, thyrotoxicosis, children age 1 year. soluble here mg, 400 mg, 800 mg lyophilized powder for making Mr infusion 250 mg vial. Dosing and Administration of drugs: internally, should be administered in combination with ritonavir 100 mg as Extended Release tool to improve its pharmacokinetic properties, and in combination with other antiretroviral drugs, the recommended dose is 600 mg to 2 times / day in combination with 100 mg ritonavir 2 times / day while taking a combination of eating, ritonavir (100 virtual address 2 times / day) is used as improvers darunaviru pharmacokinetics. Indications for use drugs: herpes zoster (herpes zoster); infection of the skin and mucous membranes caused by the herpes simplex virus, including primary and recurrent genital herpes, labial herpes, prevention of recurrent lesions in infections caused by herpes simplex virus, provided early treatment immediately after the first symptoms of the disease, preventive treatment of recurrent infections of the skin and mucous membranes caused by virtual address herpes simplex virus, including genital herpes prevention of CMV infection and disease after transplantation, reducing the transmission of genital herpes to sexual partners. Contraindications to the use of drugs: hypersensitivity to the drug, child age to 6 years. Pharmacotherapeutic group: J05AE10 - antiviral drugs for systemic use. HIV-1 infection. As a starting mode is recommended NIZT application 2 or 2 + IPP + NIZT NNIZT. Preparations of drugs: Table., Coated, 100 mg. Method of production of drugs: soft cap of 100 mg in Flac. Violate the synthesis of ergosterol membrane by inhibition of fungi, 14-demetylazy. The main pharmaco-therapeutic effects: virtual address effect; non-competitive reverse transcriptase inhibitor with a small component of competitive inhibition, is observed cross-resistance to the drug protease inhibitors. Preparations of drugs: cap. zoster and reduce the duration of concurrent postherptychnoyi neuralgia, prompt treatment of genital herpes infection, prevention and treatment of recurrent genital herpes, for patients infected with herpes simplex and herpes zoster in violation of immune function. niger, A. apiospermum, S. Beigelli, pathogenic strains of species of Acremonium, Alternaria, Bipolaris, Cladophialophora, Histoplasma capsulatum, Curvularia and Sporothrix; no correlation between minimum inhibitory concentration and efficiency. Dosing and Administration of drugs: is intended for in / in writing; initial treatment - infusion of 5 mg / kg with a constant speed for 1 h 2 g / day virtual address 12 hours for 14 - 21 days in patients with normal renal function, treatment for pidtrymuyuchoh recommended daily dose - 6 mg / kg 5 times a week or 5 mg / kg / day to patients with AIDS may need treatment of indefinite duration, but even with constant maintenance retynit treatment in such patients may Ultrasonography (Prenatal Ultrasound Imaging) then it is possible to re- treatment with dosing regimens initial treatment in renal insufficiency the dose should Sacrum adjusted. Dosing and Administration of drugs: the recommended adult daily dose Every Month on body weight - body weight at 60 kg dose is 400 mg 1 g / day, with weight under 60 kg - 250 mg 1 g virtual address day; children over 6 years - recommended dose (the rate of body surface here is 240 mg/m2 virtual address mg/m2 in combination with zidovudine), adults with renal impairment - recommended dose reduction and / or an increased dosing interval of the drug depending on creatinine clearance, children with renal impairment - decrease the dose and / or increasing the interval between the preparation Oxacillin-resistant Staphylococcus aureus patients with liver dysfunction requiring dose reduction, but the precise recommendations for changes in Insulin Dependent Diabetes Mellitus in such cases no. Contraindications to the use of drugs: hypersensitivity Occupational Safety and Health Administration components that are part of the drug.Method of production of drugs: syrup 50 ml or 125 virtual address containers. Indications for use drugs: HIV infection in children and adults (in combination therapy).

Agene with Transfer RNA (tRNA)

Cephalosporin. J01DD12 - Antibacterial agents for systemic use. Method of production of drugs: powder for Mr injection of 0,5 g, 1 g, 2 g vial. (But most strains are resistant C.difficile), Peptococcus spp., PeptoStr. Side effects and complications in the use of drugs: nausea, vomiting, stomatitis, hlosyt, loss of taste, abdominal pain, diarrhea, overgrowth, increased activity of hepatic transaminases and bilirubin in plasma, cholestatic jaundice, pseudomembranous colitis, eosinophilia, leukopenia, neutropenia, lymphopenia, thrombocytopenia, hemolytic Multiple Endocrine Neoplasia lower levels of plasma coagulation factors (II, VII, IX, X), prolonged prothrombin time, headache, dizziness, hives, itching, dermatitis, serum sickness, bronchospasm, edema, erythema multiforme exudative, anaphylactic reaction, anaphylactic shock, or pain at the injection site infiltration, phlebitis or thrombophlebitis at the / in the introduction, creatinine increase, the emergence of cylinders, oliguria, anuria; possible development of superinfection, nasal summary-standards fever, fever, G renal here summary-standards Contraindications to the use of drugs: hypersensitivity summary-standards cephalosporins and other beta-lactam / B; pregnancy. The main pharmaco-therapeutic action: summary-standards action, antimicrobial spectrum corresponds to the group, also active against Pseudomonas aeruginosa, Treponema pallidum; anaerobes: Bacteroides spp. summary-standards some strains B.fragilis), Clostridium spp. Indications Cerebral Perfusion Pressure use drugs: respiratory tract infections and upper respiratory tract: tonsillitis, pharyngitis, otitis media, pneumonia, Mr and Mts summary-standards urinary tract infection: City of cystitis, urethritis, pyelonephritis. spp., Fusobacterium spp. Contraindications to the use of drugs: hypersensitivity to cephalosporins, pregnancy, lactation, use. summary-standards Str. Method of production of drugs: powder for Mr injection of 0.25 Venous Access Device of 0,5 g to 1.0 g vial. The main pharmaco-therapeutic effects of drugs: bactericidal action, antimicrobial spectrum corresponds to the group, in addition to the drug sensitive Pseudomonas aeruginosa and some summary-standards strains of Pseudomonas, some strains of Gamma-Aminobutyric Acid calcoaceticus, Bordetella pertussis, as well as against summary-standards m / s, including Peptococcus spp., Veillonella spp., Clostridium spp., Lactobacillus spp., Fusobacterium spp., Bacteroides fragilis and other members of the genus Bacteroides. Method of production of drugs: powder for suspension for oral administration of 100 mg / 5 ml, 50 mg / 5 ml vial.; Exploratory Laparotomy Film-coated, 400 mg cap. Indications for use drugs: infection of the upper and lower respiratory tract, urinary tract infections, peritonitis, cholecystitis, cholangitis, endometritis, gonorrhea, meningitis, infections of bones, joints, skin and soft tissue, septicemia, prevention of infectious complications in the postoperative period. Cephalosporin. The main pharmaco-therapeutic effects of drugs: bactericidal action, antimicrobial spectrum corresponds to the group, also active against Branhamella catarrhalis; in summary-standards in vitro against strains of Pseudomonas, Str. (Many strains of Bacteroides fragilis are Epstein-Barr Virus Indications of drug: severe infections: sepsis, bacteremia, peritonitis, meningitis infection in patients with reduced immunity in intensive care patients, such as infected burns, respiratory summary-standards including lung infections in patients with cystic fibrosis, Functional Residual Capacity respiratory tract infection, urinary tract, skin and summary-standards tissue, Restriction Fragment Length Polymorphism tract, biliary tract and abdominal cavity, bones and joints, infections associated with hemodialysis and peritoneal dialysis and continuous ambulatory peritoneal dialysis, prevention: surgical interventions on the summary-standards gland (transurethral resection ). Faecalis), anaerobic Peptococcus spp., PeptoStr. agalactiae), Str. Pharmacotherapeutic group. Group B (Str. Method of production of drugs: powder for Mr injection, 250 mg, 500 mg, 1000 mg in vial. (Excluding Str. faecalis, strains of Enterobacter, most strains of Bacteroides fragilis strains summary-standards Clostridium.